Posts

#1 for KONEPS DB Encryption Market

koneps db encryption market share

Penta Security on top for three consecutive years. An average 39% of market share for KONEPS DB Encryption

Penta Security announced that D’Amo is number one in the “KONEPS (Korea ON-line E-Procurement System) DB Encryption Market,” with a 36% market share in 2014.

KONEPS is the Korean government procurement system. The system provides comprehensive information of all public organizations. Currently it organizes the information of over 37,000 public organizations and 120,000 private firms.

Penta Security has maintained its position as market leader for three consecutive years. According to KONEPS’ integrated procurement information system, a statistic system for the KONEPS public procurement service, the public DB encryption reached a market size of USD 32 million in 2014. D’Amo supplied for USD 11.4 million, an average of 39%.

What is D’Amo?

D’Amo is an integrated data security solution that can encrypt data in databases. It also provides key management, auditing features and a robust access control system. It can provide the best available encryption method for various DBMS environments. Some of these environments include Oracle, MS-SQL, DBS, Altibase, and Tibero. It supports various DBMS encryption methods, including the API encryption method, plug-in encryption method, hybrid method, In-place method, and Data Encryption Platform (DEP).

Penta Security COO Seokil Cho commented,

“D’Amo was the first commercial database encryption solution in Korea, and we are celebrating its 11st anniversary this year. Over the last 11 years, we have made an effort to understand and meet the needs of customers, rather than just merely become a solution to meet compliance issues. We will continue to do our best to improve the data security level of the nation.”

profile

"D’Amo for SAP”, the Encryption Solution for SAP

D’Amo for SAP, developed by data encryption and web security solution provider, Penta Security Systems Inc. (CEO Seokwoo Lee, www.pentasecurity.com), is an encryption solution that was specifically designed to run on SAP. Loads of personal data and confidential information is stored in company SAP systems. This type of information is required by law to be encrypted in many nations throughout the world, particularly in Korea, where a new privacy act has been enforced since the beginning of 2013. Moreover, sales information residing in SAP is some of the most critical data that a company is advised to secure against breach attempts.

It is not possible to encrypt data on SAP using pre-existing encryption solutions because they do not allow users to freely modify stored business application data. This makes most enterprises hesitant about adopting encryption solutions for their SAP. To overcome this limitation, Penta Security Systems Inc. released the SAP encryption solution in 2012, aptly named “D’Amo for SAP”, which comes equipped with a patented encryption technology known as FPE (Format Preserving Encryption).

The SAP Encryption Solution

D’Amo for SAP’s encryption technology has been certified by SAP, guaranteeing the stability and performance of D’Amo for SAP systems. Along with D’Amo for SAP’s encryption technology, its appliance-type KMS (Key Management Server) offers secure key management for strong authority control.

Previously, it could be quite a complicated process to encrypt data in an ERP. D’Amo for SAP and its included KMS are easily deployed in SAP systems without those complications. In addition, real-time monitoring of the system resources and auditing features make managing a secure SAP system convenient.

Penta Security’s Focus

Penta Security has recently been focusing on small and medium-sized medical centers. As a result, in March they formed an alliance with Choongwae Information Technology, an OCS/EMR provider. This alliance makes it possible to provide D’Amo for SAP together with Choongwae Information Technolgoy’s OCS/EMR product, CI OCS/EMR. CI SFE is a mobile version of CI OCS/EMR programs and is mostly used by medical centers and pharmaceutical companies.